Lenvatinib Treatment - Thyroid Cancer
Please follow this link to learn about Lenvatinib for Differentiated Thyroid Carcinoma.
This treatment is currently not reimbursed on the PBS for thyroid cancer (Differentiated Thyroid Carcinoma). However, please read about the Lenvatinib Clinical Trial.
Please discuss this treatment with your treating doctor if you think it may be suitable for you.
Consumer Medicine Information (CMI) is available here.
Tel: +61 (0) 447 834 724
PO Box 7161
Norwest NSW 2153
The mission of The Australian Thyroid Foundation Ltd (ATF) is to offer support, information and education to members and their families through the many services provided by The ATF and raise awareness about health consequences of iodine deficiency and the benefits of good thyroid health.